Annual CFF
$265.72 M
+$179.57 M+208.44%
31 October 2024
Summary:
enGene Holdings annual cash flow from financing activities is currently $265.72 million, with the most recent change of +$179.57 million (+208.44%) on 31 October 2024. During the last 3 years, it has risen by +$243.19 million (+1079.65%). ENGN annual CFF is now at all-time high.ENGN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
N/A
01 October 2024
Summary:
enGene Holdings quarterly cash flow from financing activities is not available.ENGN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
N/A
01 October 2024
Summary:
enGene Holdings TTM cash flow from financing activities is not available.ENGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENGN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +208.4% | - | - |
| 3 y3 years | +1079.7% | - | - |
| 5 y5 years | - | - | - |
ENGN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1079.7% | ||||
| 5 y | 5 years | at high | +1968.2% | ||||
| alltime | all time | at high | +1968.2% |
EnGene Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | $265.72 M(+208.4%) | - | - |
| July 2024 | - | $51.00 K(-100.0%) | $256.40 M(-9.7%) |
| Apr 2024 | - | $193.50 M(+1512.5%) | $283.90 M(+189.2%) |
| Jan 2024 | - | $12.00 M(-76.4%) | $98.16 M(+13.9%) |
| Oct 2023 | $86.15 M | $50.84 M(+84.5%) | $86.15 M(+144.0%) |
| July 2023 | - | $27.55 M(+254.9%) | $35.31 M(+103.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2023 | - | $7.76 M(<-9900.0%) | $17.36 M(+14.2%) |
| Jan 2023 | - | -$10.00 K(-100.1%) | $15.21 M(-0.1%) |
| Oct 2022 | $27.97 M(+24.2%) | - | - |
| July 2022 | - | $9.61 M(+71.5%) | $15.21 M(+171.5%) |
| Apr 2022 | - | $5.60 M | $5.60 M |
| Oct 2021 | $22.52 M(+75.3%) | - | - |
| Oct 2020 | $12.85 M | - | - |
FAQ
- What is enGene Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for enGene Holdings?
- What is enGene Holdings annual CFF year-on-year change?
- What is the all time high quarterly CFF for enGene Holdings?
- What is the all time high TTM CFF for enGene Holdings?
What is enGene Holdings annual cash flow from financing activities?
The current annual CFF of ENGN is $265.72 M
What is the all time high annual CFF for enGene Holdings?
enGene Holdings all-time high annual cash flow from financing activities is $265.72 M
What is enGene Holdings annual CFF year-on-year change?
Over the past year, ENGN annual cash flow from financing activities has changed by +$179.57 M (+208.44%)
What is the all time high quarterly CFF for enGene Holdings?
enGene Holdings all-time high quarterly cash flow from financing activities is $193.50 M
What is the all time high TTM CFF for enGene Holdings?
enGene Holdings all-time high TTM cash flow from financing activities is $283.90 M